← Back to Search

Study Cohort for Atrial Fibrillation (DETECT-POAF Trial)

N/A
Waitlist Available
Led By David Conen, MD, MPH
Research Sponsored by Population Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 14 days of continuous cardiac monitoring
Awards & highlights

Summary

This is a multicentre prospective cohort study where patients will receive up to 14 days of continuous ECG monitoring by wearing a portable monitoring device, starting within 72 hours after noncardiac surgery.

Eligible Conditions
  • Atrial Fibrillation
  • Atrial Flutter

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 14 days of continuous cardiac monitoring
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 14 days of continuous cardiac monitoring for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Incidence of clinically important post-operative atrial fibrillation/atrial flutter
Incidence of clinically important post-operative atrial fibrillation/atrial flutter define with minimum duration of 6 minutes
Incidence of clinically important post-operative atrial fibrillation/atrial flutter detected by clinical monitoring only
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Study CohortExperimental Treatment1 Intervention
Participants will receive up to 14 days of continuous cardiac monitoring

Find a Location

Who is running the clinical trial?

Population Health Research InstituteLead Sponsor
161 Previous Clinical Trials
711,384 Total Patients Enrolled
33 Trials studying Atrial Fibrillation
54,372 Patients Enrolled for Atrial Fibrillation
David Conen, MD, MPHPrincipal InvestigatorPopulation Health Research Institute
2 Previous Clinical Trials
5,479 Total Patients Enrolled
2 Trials studying Atrial Fibrillation
5,479 Patients Enrolled for Atrial Fibrillation
Michael K Wang, MDPrincipal InvestigatorPopulation Health Research Institute
~500 spots leftby Aug 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top